bpc-157 legal status eu BPC-157: Experimental Peptide Creates Risk for Athletes What Is BPC-157? A Medical
Description
In animal studies, administration of BPC 157 following the damage caused by these drugs has shown that damage such as ventricular tachycardia, bradycardia, T wave elevation, QTc prolongation and asystole can be completely resolved in mice
GHK-Cu vials are available in two concentrations
The usual frequency for intramuscular doses of B12 shots is every 10 days, followed by maintenance doses at varying intervals
They also have potentially serious side effects that require close monitoring by the doctor
